T. Ogi

A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)

M. Nishimura, H. Dosaka-akita, T. Harada, 2017, Cancer Chemotherapy and Pharmacology.

Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family

M. Nishimura, Y. Matsuno, Y. Niida, 2019, PloS one.

Clinical Course of Histologically Proven Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: A Case Series and Comparison with Lymphangiomyomatosis

M. Nishimura, Y. Matsuno, S. Konno, 2018, Respiration.

Extraskeletal osteosarcoma of the lung following treatment of primary small-cell lung carcinoma with chemoradiotherapy: A case report.

Makoto Yamamoto, K. Takamura, T. Ogi, 2017, Molecular and clinical oncology.

A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)

M. Nishimura, H. Dosaka-akita, T. Harada, 2018, International Journal of Clinical Oncology.

Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials

M. Nishimura, H. Dosaka-akita, T. Harada, 2018, Frontiers in Pharmacology.

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).

M. Nishimura, H. Dosaka-akita, T. Kojima, 2019, Lung cancer.

First clinical isolation report of azole-resistant Aspergillus fumigatus with TR34/L98H-type mutation in Japan.

D. Hagiwara, T. Toyotome, K. Kamei, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)

M. Nishimura, H. Dosaka-akita, T. Harada, 2018, International Journal of Clinical Oncology.

A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)

M. Nishimura, H. Dosaka-akita, T. Harada, 2017, Cancer Chemotherapy and Pharmacology.

Extraskeletal osteosarcoma of the lung following treatment of primary small-cell lung carcinoma with chemoradiotherapy: A case report.

Makoto Yamamoto, K. Takamura, T. Ogi, 2017, Molecular and clinical oncology.